|Mellon Bank Ctr., 1735 Market St.- 37th Fl. , Philadelphia, PA 19103|
|Fund Manager||Team Managed|
The Aberdeen Global Absolute Return Strategies Fund (formerly, Aberdeen Global Unconstrained Fixed Income Fund) (the â€œGARSÂ® Fundâ€ or the â€œFundâ€) seeks to generate a positive absolute return over the medium to long term (3-5 years or more) irrespective of market conditions, while seeking to reduce the risk of loss. The GARSÂ® Fund employs an â€œabsolute returnâ€ investment approach. This means that in pursuing the Fundâ€™s investment objective, the Fund benchmarks itself to an index of cash instruments, rather than a stock or bond market index, and seeks to achieve positive long term returns irrespective of broad movements in the bond and equity markets. As an â€œabsolute returnâ€ fund, the GARSÂ® Fund employs investment management techniques that may differ from traditional mutual funds. The GARSÂ® Fund may use an extensive range of investment strategies and invest in a wide spectrum of equity and fixed-income securities and derivative instruments in pursuing its investment objective. The GARSÂ® Fund also may hold significant amounts of cash and/or invest significantly in cash equivalents and short-term investments, including money market funds. The GARSÂ® Fund may invest in equity and fixed-income securities of companies and government and supranational entities around the world, including in emerging markets. The GARSÂ® Fund is not subject to any maturity, market capitalization, or credit quality restrictions and may invest in high-yield below-investment-grade bonds (junk bonds) without limitation.
|Asset Type||% Of Allocation|
|Total Net Assets||490.00 K|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$1000|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 05/31/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 05/31/2021|
|Life Of Fund||
Join the Action Alerts PLUS Community today!
AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.
Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.
Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.
DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.
Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.
Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.
Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'
Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.
Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.
'Lehman moment' or managed failure? Either result has global markets rattled by the impending default of property developer China Evergrande.